CIK 0001035354
- Non-accelerated filer
- Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841368850
- Phone
- +1 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 2,466,666 shares at $1.35 ($3,329,999)
- 4 Open-market buy 10% owner bought 5,925,925 shares at $1.35 ($7,999,999)
- 4 Open-market buy Director bought 5,925,925 shares at $1.35 ($7,999,999)
- 4 Open-market buy Director bought 5,925,925 shares at $1.35 ($7,999,999)
- 4 Shares withheld for taxes COO, GENERAL COUNSEL &CORP SEC gave up 459 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 2,532,270 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes COO, GENERAL COUNSEL &CORP SEC gave up 7,338 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 15,360 shares (to pay taxes)
Page 4 of 29 · 574 filings